Join Growin Stock Community!
Back to CELH.US Analysis
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

pe-stream-chart

CELH PE Ratio River

PE Ratio River

Browsing restrictions can be lifted for a fee.

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

Based on the latest data from August 2025, CELH is trading at $62.88, which falls between the 31.0x PE multiple ($17.00) and the 280.3x PE multiple ($153.60). This positions the stock in the "Value" zone, suggesting the shares are attractively priced relative to historical PE ratios. The current price significantly exceeds the lowest PE boundary of 31.0 times but remains well below the higher valuation thresholds, indicating potential investment value for investors seeking exposure to the stock at reasonable multiples. The historical trend reveals a dramatic valuation expansion and subsequent contraction cycle. From 2020 to early 2022, CELH traded primarily in the "Undervalued" and "Value" zones, with prices consistently below $40. The stock experienced explosive growth through 2023 and early 2024, reaching peak prices near $88 in March 2024, which pushed valuations into the upper PE bands approaching "Overvalued" territory. However, since mid-2024, the stock has undergone a significant correction, declining from those peaks back toward more reasonable valuation levels. The PE river boundaries themselves have expanded substantially over time, reflecting the company's growing earnings base, with the upper boundary (1277.2x PE) rising from around $70 in 2020 to over $699 currently. This valuation compression from recent highs, combined with the stock's current positioning in the "Value" zone, suggests a more attractive risk-reward profile compared to the elevated levels seen in early 2024.